of GIST


Authors

Year

Country

Study period

Study type

KIT immunohistochemistry

Peak incidence (per 1,000,000)

Median age at diagnosis (years)

Goettsch et al. [15]

2005

Netherlands

1995–2003

Retrospective pathology review

Partial (87 %)

12.7

Not reported

Tryggvason et al. [14]

2005

Iceland

1990–2003

Retrospective pathology review

Yes

11a

65.8

Tran et al. [10]

2005

United States

1992–2000

SEER analysis

No

6.8a

63

Nilsson et al. [13]

2005

Western Sweden

1983–2000

Retrospective pathology review

Yes

14.5

69

Chan et al. [21]

2006

China

1995–2003

Retrospective pathology review

Yes

19.6a

66.6

Perez et al. [11]

2006

United States

1992–2002

SEER analysis

No

6.88a

63

Mucciarini et al. [17]

2007

Italy

1991–2004

Modena Cancer Registry analysis

Yes

6.6

69

Tzen et al. [19]

2007

Taiwan

1998–2004

Retrospective pathology review

Yes

13.74

Not reported

Ahmed et al. [16]

2008

United Kingdom

1987–2003

Retrospective pathology review

Yes

13.2

64.4

Monges et al. [18]

2010

France

2005

Prospective pathology review

Yes

10

65

Rubin et al. [12]

2011

United States

1993–2002

SEER analysis

No

3.2a

75

Chiang et al. [20]

2014

Taiwan

1998–2008

Taiwan Cancer Registry analysis

No

19.7a

62–64

Ma et al. [23]

2015

United States

2001–2011

SEER analysis

No

7.8a

64


aOriginally reported per 100,000 persons. Data standardized as cases per million persons





4 Conclusion


In conclusion, many studies around the world have attempted to identify the incidence of GIST, ranging from national database analyses in the United States to retrospective pathological analyses conducted throughout Europe and Asia. The incidence of disease varies from 2.1 to 19.7 cases per million persons. GIST appears to be slightly more common in males than females with an average age range in the mid-60s and peak incidence in the 70s. For unclear reasons, race appears to be a factor in disease development with African Americans and Asian/Pacific Islanders being more commonly affected than Caucasians. As reported in every study, it is clear that the stomach is the most common tumor location followed by the small intestine. Finally, risk factors for death secondary to disease include increased age at diagnosis, male sex, Black race, and regional/metastatic disease. Despite increased understanding of the epidemiology of GIST over the last two decades, further studies are warranted to better define the incidence, prevalence, and risk factors for developing GIST.


References



1.

Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol. 1983;7(6):507–19.CrossRefPubMed


2.

Herrera GA, Pinto de Moraes H, Grizzle WE, Han SG. Malignant small bowel neoplasm of enteric plexus derivation (plexosarcoma). Light and electron microscopic study confirming the origin of the neoplasm. Dig Dis Sci. 1984;29(3):275–84.CrossRefPubMed


3.

Herrera GA, Cerezo L, Jones JE, et al. Gastrointestinal autonomic nerve tumors. ‘Plexosarcomas’. Arch Pathol Lab Med. 1989;113(8):846–53.PubMed


4.

Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279(5350):577–80.CrossRefPubMed

Jun 30, 2017 | Posted by in GASTOINESTINAL SURGERY | Comments Off on of GIST

Full access? Get Clinical Tree

Get Clinical Tree app for offline access